Zevra Therapeutics, Inc. (ZVRA)
8.17
-0.16
(-1.92%)
USD |
NASDAQ |
Dec 15, 16:00
8.10
-0.07
(-0.86%)
Pre-Market: 09:26
Zevra Therapeutics Cash and Short Term Investments (Quarterly): 199.51M for Sept. 30, 2025
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Nektar Therapeutics | 270.21M |
| XOMA Royalty Corp. | 92.00M |
| Akebia Therapeutics, Inc. | 168.14M |
| NovaBay Pharmaceuticals, Inc. | 2.309M |
| Palatin Technologies, Inc. | 1.273M |